US EditionPharma Prepared to Work with Trump on DTC Drug Sales: Pfizer CEO
UNITED STATES, AUG 5 – Pfizer raised its profit forecast despite U.S. government pressure to lower drug prices and expand direct-to-consumer options, with adjusted earnings per share guidance up by 10 cents.
Summary by biopharmadive.com
6 Articles
6 Articles
Updated: Pfizer CEO says drugmakers are ready to work with Trump on direct sales program
Drugmakers are ready to work with the Trump administration and start direct-to-consumer sales programs, Pfizer CEO Albert Bourla said Tuesday during the company's earnings call. Bourla said he was speaking as the chair of the ...
Despite the US customs dispute and the threat of price reductions for the year as a whole, Pfizer expects more profit than before.
Pharmaceutical company Pfizer expects to post higher profits this year than forecast. The company's new forecast takes into account US import tariffs and US President Donald Trump's demand for significant drug price reductions.
·Apeldoorn, Netherlands
Read Full ArticleCoverage Details
Total News Sources6
Leaning Left2Leaning Right0Center1Last UpdatedBias Distribution67% Left
Bias Distribution
- 67% of the sources lean Left
67% Left
L 67%
C 33%
Factuality
To view factuality data please Upgrade to Premium
